ArticleScientific reports2025
Antioxidative effects of phytoaromatic compounds on the cysteine of the SKCGS peptide as a critical aggregation domain of tau.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cysteine residues play a crucial role in maintaining the structural and functional integrity of proteins, but they are highly susceptible to oxidative modifications. These modifications can contribute to disorders such as Alzheimer's disease (AD). In tau protein, the SKCGS sequence, especially the cysteine residue at position C-322, is particularly vulnerable to oxidative stress (OS). This vulnerability promotes tau fibrillation and aggregation, both in vitro and in vivo. This study evaluated the antioxidative effects of cinnamaldehyde (Cin), phenylethyl alcohol (PEA), and the common crude spices (cinnamon, rose, saffron, and cardamom) on the SKCGS peptide of the tau protein (in solution and aroma forms), with a focus on their ability to prevent oxidative damage. We adopted a novel approach using aromatherapy that utilizes the aromatic and volatile properties of natural compounds. By combining biochemical assessments with molecular docking studies, we aimed to provide a comprehensive understanding of the protective mechanisms of the natural phytoaromatic compounds used in this study. The antioxidative potential of these compounds was assessed using the DPPH assay; thiol levels measured via DTNB and mBBr assays; and binding interactions evaluated through molecular docking. The DPPH assay confirmed the antioxidative activity of all tested compounds. DTNB and mBBr assays showed that the phytoaromatic compounds significantly preserved free thiol content in the SKCGS peptide under oxidative conditions (p < 0.05). Molecular docking predicted favorable binding interactions between the phytoaromatic compounds and the cysteine residue in the SKCGS sequence, suggesting a protective mechanism against OS. The data presented provided strong evidence supporting the idea that phytoaromatic compounds could be promising candidates for developing innovative treatment approaches for AD. The encouraging results from this study justify further exploration of phytoaromatic compounds as therapeutic agents for AD. This research opens up new avenues for creating effective treatments to address one of the most significant challenges in neurodegenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.